hba1c

4 interactions related to hba1c

mk-677 + insulin

MK-677 raises growth hormone, and growth hormone reduces the body's sensitivity to insulin. Across multiple controlled trials this shows up as rising fasting blood sugar and rising HbA1c. In a two-year randomised trial, sixteen of forty-three participants taking MK-677 crossed into the impaired fasting glucose range, against two of twenty-two on placebo, and insulin sensitivity fell measurably. A more recent six-month trial saw HbA1c rise significantly, with two of thirteen participants stopping because of high blood sugar. This works directly against what insulin is prescribed to do.

high
mk-677ibutamoreninsulingrowth hormoneinsulin resistanceblood sugarhba1c

mk-677 + metformin

MK-677 raises growth hormone, and growth hormone reduces the body's sensitivity to insulin. Across multiple controlled trials this shows up as rising fasting blood sugar and rising HbA1c. In a two-year randomised trial, sixteen of forty-three participants taking MK-677 crossed into the impaired fasting glucose range, against two of twenty-two on placebo, and insulin sensitivity fell measurably. A more recent six-month trial saw HbA1c rise significantly, with two of thirteen participants stopping because of high blood sugar. This works directly against what metformin is prescribed to do.

moderate
mk-677ibutamorenmetformingrowth hormoneinsulin resistanceblood sugarhba1c

smoking + insulin

Smoking worsens insulin resistance through nicotine-driven catecholamine release, oxidative stress, and inflammation, and slows subcutaneous insulin absorption through vasoconstriction, so people with diabetes who smoke typically need more insulin to reach the same glucose control. Quitting improves insulin sensitivity within days to weeks, so insulin doses often need to come down to avoid hypoglycemia.

high
smokinginsulindiabetestobaccoinsulin resistancehba1cdrug interactionsmoking cessationblood sugar

ginger tea + metformin

Ginger (Zingiber officinale) has modest blood-glucose-lowering activity in randomized trials in type 2 diabetes, mainly improving fasting glucose and HbA1c. Combined with metformin the effect is generally additive rather than dangerous. Metformin alone rarely causes hypoglycemia, so the practical concern is small; the risk of a true low rises mainly when ginger is layered onto insulin or an insulin-secreting drug.

low
gingermetformindiabetesblood sugarhypoglycemiahba1cherbal teatype 2 diabetes